Yield10 Bioscience, Inc. (YTEN)
USD 0.34
(0.0%)
USD 0.34
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -14.12 Million USD | -7.12% |
| 2022 | -13.18 Million USD | -8.35% |
| 2021 | -11.47 Million USD | -38.27% |
| 2020 | -9.42 Million USD | -79.07% |
| 2019 | -8.39 Million USD | 46.11% |
| 2018 | -9.12 Million USD | -1.77% |
| 2017 | -9.07 Million USD | 7.54% |
| 2016 | -10.07 Million USD | 58.81% |
| 2015 | -12.35 Million USD | 10.78% |
| 2014 | -26.32 Million USD | 10.62% |
| 2013 | -27.61 Million USD | -702.31% |
| 2012 | 4.9 Million USD | 113.12% |
| 2011 | -37.35 Million USD | -0.17% |
| 2010 | -37.29 Million USD | -3.6% |
| 2009 | -35.99 Million USD | -2.37% |
| 2008 | -35.16 Million USD | -8.64% |
| 2007 | -32.36 Million USD | -95.44% |
| 2006 | -16.56 Million USD | -175.54% |
| 2005 | -6.71 Million USD | -26.93% |
| 2004 | -4.73 Million USD | -298.68% |
| 2003 | 2.38 Million USD | 147.06% |
| 2002 | -5.06 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -3.2 Million USD | -32.39% |
| 2024 Q1 | -2.44 Million USD | 25.2% |
| 2023 FY | - USD | -7.12% |
| 2023 Q2 | -3.59 Million USD | 3.75% |
| 2023 Q4 | -3.17 Million USD | 14.29% |
| 2023 Q1 | -3.73 Million USD | -16.45% |
| 2023 Q3 | -3.7 Million USD | -3.12% |
| 2022 Q2 | -3.36 Million USD | -3.22% |
| 2022 FY | - USD | -8.35% |
| 2022 Q3 | -3.42 Million USD | -1.6% |
| 2022 Q4 | -3.2 Million USD | 6.34% |
| 2022 Q1 | -3.26 Million USD | -9.91% |
| 2021 FY | - USD | -38.27% |
| 2021 Q2 | -3.02 Million USD | -21.18% |
| 2021 Q1 | -2.49 Million USD | 4.29% |
| 2021 Q3 | -3.73 Million USD | -23.36% |
| 2021 Q4 | -2.96 Million USD | 20.51% |
| 2020 FY | - USD | -79.07% |
| 2020 Q1 | -1.66 Million USD | -256.59% |
| 2020 Q2 | -2.42 Million USD | -45.94% |
| 2020 Q3 | -2.14 Million USD | 11.5% |
| 2020 Q4 | -2.61 Million USD | -21.51% |
| 2019 FY | - USD | 46.11% |
| 2019 Q1 | -2.23 Million USD | -18.5% |
| 2019 Q2 | -1.84 Million USD | 17.32% |
| 2019 Q3 | -1.94 Million USD | -5.41% |
| 2019 Q4 | 1.06 Million USD | 154.52% |
| 2018 FY | - USD | -1.77% |
| 2018 Q3 | -2.61 Million USD | -10.12% |
| 2018 Q4 | -1.88 Million USD | 27.77% |
| 2018 Q1 | -2.26 Million USD | 9.82% |
| 2018 Q2 | -2.37 Million USD | -4.91% |
| 2017 Q4 | -2.5 Million USD | -32.8% |
| 2017 FY | - USD | 7.54% |
| 2017 Q3 | -1.88 Million USD | 28.58% |
| 2017 Q2 | -2.64 Million USD | -33.64% |
| 2017 Q1 | -1.97 Million USD | -69.85% |
| 2016 FY | - USD | 58.81% |
| 2016 Q4 | -1.16 Million USD | 55.56% |
| 2016 Q3 | -2.61 Million USD | 15.81% |
| 2016 Q2 | -3.11 Million USD | 51.23% |
| 2016 Q1 | -6.37 Million USD | -10.19% |
| 2015 Q1 | -5.76 Million USD | 1.01% |
| 2015 Q4 | -5.78 Million USD | 2.13% |
| 2015 Q3 | -5.91 Million USD | 3.65% |
| 2015 Q2 | -6.13 Million USD | -6.56% |
| 2015 FY | - USD | 10.78% |
| 2014 Q4 | -5.82 Million USD | 12.07% |
| 2014 FY | - USD | 10.62% |
| 2014 Q1 | -7.97 Million USD | 7.38% |
| 2014 Q2 | -7.23 Million USD | 9.17% |
| 2014 Q3 | -6.61 Million USD | 8.56% |
| 2013 Q1 | -6.5 Million USD | 29.69% |
| 2013 Q2 | -7.6 Million USD | -16.89% |
| 2013 FY | - USD | -702.31% |
| 2013 Q3 | -7.01 Million USD | 7.67% |
| 2013 Q4 | -8.6 Million USD | -22.63% |
| 2012 Q2 | -7.61 Million USD | -126.09% |
| 2012 FY | - USD | 113.12% |
| 2012 Q4 | -9.24 Million USD | -24.38% |
| 2012 Q3 | -7.43 Million USD | 2.4% |
| 2012 Q1 | 29.2 Million USD | 415.9% |
| 2011 Q2 | -9.61 Million USD | -3.7% |
| 2011 Q1 | -9.27 Million USD | -2.61% |
| 2011 Q3 | -9.21 Million USD | 4.2% |
| 2011 Q4 | -9.24 Million USD | -0.31% |
| 2011 FY | - USD | -0.17% |
| 2010 FY | - USD | -3.6% |
| 2010 Q3 | -9.63 Million USD | -4.7% |
| 2010 Q1 | -9.42 Million USD | -3.42% |
| 2010 Q2 | -9.19 Million USD | 2.37% |
| 2010 Q4 | -9.04 Million USD | 6.14% |
| 2009 FY | - USD | -2.37% |
| 2009 Q4 | -9.11 Million USD | -3.28% |
| 2009 Q1 | -8.83 Million USD | -5.46% |
| 2009 Q2 | -9.91 Million USD | -12.24% |
| 2009 Q3 | -8.82 Million USD | 11.02% |
| 2008 Q3 | -9.31 Million USD | -6.65% |
| 2008 Q4 | -8.37 Million USD | 10.12% |
| 2008 Q2 | -8.73 Million USD | -0.07% |
| 2008 Q1 | -8.73 Million USD | -9.33% |
| 2008 FY | - USD | -8.64% |
| 2007 FY | - USD | -95.44% |
| 2007 Q3 | -9.48 Million USD | -6.29% |
| 2007 Q2 | -8.91 Million USD | -49.17% |
| 2007 Q1 | -5.97 Million USD | 26.44% |
| 2007 Q4 | -7.98 Million USD | 15.76% |
| 2006 Q1 | -242.15 Thousand USD | 97.36% |
| 2006 Q2 | -2.09 Million USD | -766.93% |
| 2006 Q3 | -4.18 Million USD | -99.34% |
| 2006 Q4 | -8.12 Million USD | -94.23% |
| 2006 FY | - USD | -175.54% |
| 2005 Q2 | 807.46 Thousand USD | 15.12% |
| 2005 Q1 | 701.41 Thousand USD | 109.04% |
| 2005 FY | - USD | -26.93% |
| 2005 Q4 | -9.16 Million USD | -1541.63% |
| 2005 Q3 | 636.05 Thousand USD | -21.23% |
| 2004 Q1 | 919.55 Thousand USD | 0.0% |
| 2004 FY | - USD | -298.68% |
| 2004 Q2 | 919.55 Thousand USD | 0.0% |
| 2004 Q4 | -7.75 Million USD | -943.77% |
| 2004 Q3 | 919.55 Thousand USD | 0.0% |
| 2003 FY | - USD | 147.06% |
| 2002 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bioceres Crop Solutions Corp. | 54.15 Million USD | 126.087% |
| Muliang Viagoo Technology, Inc. | 467.3 Thousand USD | 3123.105% |
| N2OFF, Inc. | -7.51 Million USD | -87.948% |
| Arcadia Biosciences, Inc. | -13.93 Million USD | -1.356% |